​USA- FDA Approves New Treatment for Sickle Cell Disease.

(This article was first published on Medscape.) The US Food and Drug Administration (FDA) has approved L-glutamine oral powder (Endari, Emmaus Medical Inc) to reduce severe complications of sickle cell disease in patients aged 5 years and older with the disorder. This is the first approval for the rare disorder in almost 20 years. “Endari Read more about ​USA- FDA Approves New Treatment for Sickle Cell Disease.[…]